Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
16.53
-0.31 (-1.84%)
At close: Jun 6, 2025, 4:00 PM
16.70
+0.17 (1.03%)
After-hours: Jun 6, 2025, 7:41 PM EDT

Cellebrite DI Statistics

Total Valuation

Cellebrite DI has a market cap or net worth of $3.96 billion. The enterprise value is $3.46 billion.

Market Cap 3.96B
Enterprise Value 3.46B

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

Cellebrite DI has 239.47 million shares outstanding. The number of shares has increased by 13.90% in one year.

Current Share Class 239.47M
Shares Outstanding 239.47M
Shares Change (YoY) +13.90%
Shares Change (QoQ) +0.79%
Owned by Insiders (%) 2.71%
Owned by Institutions (%) 37.39%
Float 107.41M

Valuation Ratios

PE Ratio n/a
Forward PE 35.05
PS Ratio 8.66
Forward PS 7.72
PB Ratio 10.79
P/TBV Ratio 12.22
P/FCF Ratio 29.63
P/OCF Ratio 27.68
PEG Ratio 2.25
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 49.08, with an EV/FCF ratio of 25.89.

EV / Earnings n/a
EV / Sales 8.25
EV / EBITDA 49.08
EV / EBIT 57.72
EV / FCF 25.89

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.03.

Current Ratio 1.82
Quick Ratio 1.70
Debt / Equity 0.03
Debt / EBITDA 0.14
Debt / FCF 0.08
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -115.35% and return on invested capital (ROIC) is 20.79%.

Return on Equity (ROE) -115.35%
Return on Assets (ROA) 6.05%
Return on Invested Capital (ROIC) 20.79%
Return on Capital Employed (ROCE) 14.20%
Revenue Per Employee $359,186
Profits Per Employee -$166,440
Employee Count 1,167
Asset Turnover 0.68
Inventory Turnover 7.33

Taxes

In the past 12 months, Cellebrite DI has paid $6.91 million in taxes.

Income Tax 6.91M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +57.13% in the last 52 weeks. The beta is 1.32, so Cellebrite DI's price volatility has been higher than the market average.

Beta (5Y) 1.32
52-Week Price Change +57.13%
50-Day Moving Average 18.46
200-Day Moving Average 19.26
Relative Strength Index (RSI) 36.19
Average Volume (20 Days) 1,623,565

Short Selling Information

The latest short interest is 1.81 million, so 0.75% of the outstanding shares have been sold short.

Short Interest 1.81M
Short Previous Month 988,163
Short % of Shares Out 0.75%
Short % of Float 1.68%
Short Ratio (days to cover) 1.64

Income Statement

In the last 12 months, Cellebrite DI had revenue of $419.17 million and -$194.24 million in losses. Loss per share was -$0.89.

Revenue 419.17M
Gross Profit 352.35M
Operating Income 59.93M
Pretax Income -106.25M
Net Income -194.24M
EBITDA 70.49M
EBIT 59.93M
Loss Per Share -$0.89
Full Income Statement

Balance Sheet

The company has $409.49 million in cash and $10.60 million in debt, giving a net cash position of $499.19 million or $2.08 per share.

Cash & Cash Equivalents 409.49M
Total Debt 10.60M
Net Cash 499.19M
Net Cash Per Share $2.08
Equity (Book Value) 363.49M
Book Value Per Share 1.53
Working Capital 235.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $143.01 million and capital expenditures -$9.41 million, giving a free cash flow of $133.60 million.

Operating Cash Flow 143.01M
Capital Expenditures -9.41M
Free Cash Flow 133.60M
FCF Per Share $0.56
Full Cash Flow Statement

Margins

Gross margin is 84.06%, with operating and profit margins of 14.30% and -46.34%.

Gross Margin 84.06%
Operating Margin 14.30%
Pretax Margin -44.69%
Profit Margin -46.34%
EBITDA Margin 16.82%
EBIT Margin 14.30%
FCF Margin 31.87%

Dividends & Yields

Cellebrite DI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.90%
Shareholder Yield -13.90%
Earnings Yield -4.91%
FCF Yield 3.38%
Dividend Details

Analyst Forecast

The average price target for Cellebrite DI is $22.43, which is 35.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target $22.43
Price Target Difference 35.69%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 15.67%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Cellebrite DI has an Altman Z-Score of 7.13 and a Piotroski F-Score of 4.

Altman Z-Score 7.13
Piotroski F-Score 4